|
Volumn 2, Issue 10, 2010, Pages 670-682
|
Metallo-allixinate complexes with anti-diabetic and anti-metabolic syndrome activities
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADIPOCYTES;
COPPER AND ZINC;
DIABETES MELLITUS;
EATING HABITS;
EXPERIMENTAL ANIMALS;
INSULIN INJECTIONS;
INSULIN RESISTANCE;
INSULIN SECRETION;
METABOLIC SYNDROMES;
ORAL ADMINISTRATION;
ORALLY ACTIVE;
THERAPEUTIC APPLICATION;
TYPE 1 DIABETES;
TYPE-2 DIABETES;
VANADYL;
ZINC COMPLEX;
AMINO ACIDS;
ANIMALS;
COPPER;
COPPER COMPOUNDS;
INSULIN;
METABOLISM;
METAL COMPLEXES;
METAL IONS;
METALS;
PHYSIOLOGY;
SULFUR;
ZINC;
VANADIUM COMPOUNDS;
ALLIXIN;
ANTIDIARRHEAL AGENT;
ANTIMETABOLITE;
COPPER COMPLEX;
CYSTEINE;
INSULIN;
METAL ION;
METALLO ALLIXINATE;
THIOXOALLIXIN N METHYL;
UNCLASSIFIED DRUG;
VANADIUM;
VANADYL DERIVATIVE;
ZINC COMPLEX;
DIABETES MELLITUS;
DIET;
DRUG STRUCTURE;
DRUG SYNTHESIS;
HYPOGLYCEMIA;
INSULIN DEPENDENT DIABETES MELLITUS;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NONHUMAN;
PANCREAS ISLET BETA CELL;
PRIORITY JOURNAL;
REVIEW;
DIABETES MELLITUS;
HUMANS;
HYPOGLYCEMIC AGENTS;
METABOLIC SYNDROME X;
MOLECULAR STRUCTURE;
PYRONES;
VANADATES;
ALLIUM SATIVUM;
ANIMALIA;
|
EID: 77957790356
PISSN: 17565901
EISSN: 1756591X
Source Type: Journal
DOI: 10.1039/c0mt00025f Document Type: Review |
Times cited : (43)
|
References (85)
|